High cost drugs - Risankizumab



Codelist metadata

Coding system

No coding system

Coding system release

unknown

Organisation

OpenSAFELY

Codelist ID

opensafely/high-cost-drugs-risankizumab

Version ID

60a81e58

Versions

About

Description

This is a list of all the unique values from the Drug Name variable in the High Cost Drugs Dataset that relate to the prescribing of risankizumab.

Methodology

The values in this variable do not follow a coding system so the selection for this codelist is based on the drug name value, after converting all text to lower case, containing one or more of the following strings (these are the generic medicine name and brand names):

  • risankizumab
  • skyrizi

All drug name values that contain at least one of the above strings are included in the risankizumab group and assigned the VTM (virtual therapeutic moiety) code 37138511000001104.

References

Signed off by

  • Mark Yates, (Feb. 26, 2021)
  • Nick Kennedy, (Feb. 26, 2021)
  • Anna Rowan, (Feb. 26, 2021)
  • Sinéad langan, (Feb. 26, 2021)
  • James Galloway, (Feb. 26, 2021)

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

olddrugname
home-risankizumab 75mg/0.83ml solution for inj pfs
home - risankizumab 75mg-0.83ml solution for inj pfs
risankizumab
risankizumab ( (homecare)
risankizumab (home) 75 mg subcutaneous injection
risankizumab (skyrizi - homecare) 75 mg in 0.83ml pre-filled syringe
risankizumab 75mg in 0.83ml (skyrizi) (homecare) 75 mg pre-filled syringe
risankizumab 75mg/0.83ml solution for injection (2)
risankizumab pas scheme (skyrizi) 75 mg pre-filled syringe
risankizumab pas scheme (skyrizi)_(homecare) 75 mg pre-filled syringe
skyrizi
skyrizi (risankizumab)
skyrizi (risankizumab) (homecare)